Amprius Technologies (NYSE:AMPX) Trading Down 1.9% After Insider Selling

Amprius Technologies, Inc. (NYSE:AMPXGet Free Report) shares fell 1.9% on Thursday following insider selling activity. The company traded as low as $17.69 and last traded at $18.2450. 10,663,625 shares were traded during mid-day trading, an increase of 15% from the average session volume of 9,261,216 shares. The stock had previously closed at $18.59.

Specifically, Director Steven Chu sold 155,565 shares of the business’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Steven Chu sold 166,632 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $17.92, for a total transaction of $2,986,045.44. Following the completion of the sale, the director owned 127,339 shares of the company’s stock, valued at approximately $2,281,914.88. The trade was a 56.68% decrease in their position. The disclosure for this sale is available in the SEC filing.

Analyst Ratings Changes

AMPX has been the topic of a number of research reports. Needham & Company LLC restated a “buy” rating and set a $20.00 price objective on shares of Amprius Technologies in a research report on Tuesday. B. Riley Financial boosted their price target on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a report on Monday, March 9th. Oppenheimer reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Amprius Technologies in a report on Tuesday, December 23rd. Craig Hallum lifted their target price on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Finally, Roth Mkm reissued a “buy” rating and issued a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Amprius Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Check Out Our Latest Stock Report on AMPX

Amprius Technologies News Roundup

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
  • Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
  • Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
  • Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
  • Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

Amprius Technologies Stock Down 2.0%

The stock’s 50-day moving average price is $11.88 and its 200-day moving average price is $11.07. The company has a market capitalization of $2.46 billion, a price-to-earnings ratio of -52.72 and a beta of 3.04.

Amprius Technologies (NYSE:AMPXGet Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, equities research analysts anticipate that Amprius Technologies, Inc. will post -0.45 EPS for the current year.

Hedge Funds Weigh In On Amprius Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. EWA LLC boosted its holdings in shares of Amprius Technologies by 3.8% in the fourth quarter. EWA LLC now owns 19,958 shares of the company’s stock valued at $157,000 after buying an additional 723 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Amprius Technologies by 14.7% during the third quarter. Victory Capital Management Inc. now owns 11,817 shares of the company’s stock worth $124,000 after acquiring an additional 1,516 shares during the period. Graham Capital Management L.P. boosted its stake in Amprius Technologies by 3.2% in the 4th quarter. Graham Capital Management L.P. now owns 49,596 shares of the company’s stock worth $391,000 after purchasing an additional 1,551 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Amprius Technologies by 5.1% during the fourth quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company’s stock worth $263,000 after buying an additional 1,621 shares during the period. Finally, First Trust Advisors LP boosted its position in Amprius Technologies by 6.7% during the 4th quarter. First Trust Advisors LP now owns 32,744 shares of the company’s stock worth $258,000 after acquiring an additional 2,066 shares during the last quarter. 5.04% of the stock is owned by institutional investors.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Further Reading

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.